687 related articles for article (PubMed ID: 11456360)
1. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster.
Lin WR; Lin HH; Lee SS; Tsai HC; Huang CK; Wann SR; Chen YS; Chiang SC; Yen MY; Liu YC
J Microbiol Immunol Infect; 2001 Jun; 34(2):138-42. PubMed ID: 11456360
[TBL] [Abstract][Full Text] [Related]
2. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults.
Beutner KR; Friedman DJ; Forszpaniak C; Andersen PL; Wood MJ
Antimicrob Agents Chemother; 1995 Jul; 39(7):1546-53. PubMed ID: 7492102
[TBL] [Abstract][Full Text] [Related]
3. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus.
Colin J; Prisant O; Cochener B; Lescale O; Rolland B; Hoang-Xuan T
Ophthalmology; 2000 Aug; 107(8):1507-11. PubMed ID: 10919899
[TBL] [Abstract][Full Text] [Related]
5. The change in zoster-associated pain treated with oral valaciclovir in immunocompetent patients with acute herpes zoster.
Kurokawa I; Murakawa K; Kumano K
Int J Clin Pract; 2007 Jul; 61(7):1223-9. PubMed ID: 17362479
[TBL] [Abstract][Full Text] [Related]
6. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older.
Arora A; Mendoza N; Brantley J; Yates B; Dix L; Tyring S
J Infect Dis; 2008 May; 197(9):1289-95. PubMed ID: 18422441
[TBL] [Abstract][Full Text] [Related]
7. Valaciclovir: a review of its use in the management of herpes zoster.
Ormrod D; Goa K
Drugs; 2000 Jun; 59(6):1317-40. PubMed ID: 10882165
[TBL] [Abstract][Full Text] [Related]
8. Comparison of valaciclovir and acyclovir for the treatment of herpes zoster in immunocompetent patients over 50 years of age: a cost-consequence model.
Grant DM; Mauskopf JA; Bell L; Austin R
Pharmacotherapy; 1997; 17(2):333-41. PubMed ID: 9085325
[TBL] [Abstract][Full Text] [Related]
9. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
Perry CM; Faulds D
Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
[TBL] [Abstract][Full Text] [Related]
10. Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older.
Madkan VK; Arora A; Babb-Tarbox M; Aboutlabeti S; Tyring S
J Cutan Med Surg; 2007; 11(3):89-98. PubMed ID: 17511925
[TBL] [Abstract][Full Text] [Related]
11. Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, double-blind, active-controlled trial.
Tyring SK; Plunkett S; Scribner AR; Broker RE; Herrod JN; Handke LT; Wise JM; Martin PA;
J Med Virol; 2012 Aug; 84(8):1224-32. PubMed ID: 22711350
[TBL] [Abstract][Full Text] [Related]
12. Valacyclovir for the treatment of genital herpes.
Brantley JS; Hicks L; Sra K; Tyring SK
Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir. Valaciclovir International Zoster Assessment Group (VIZA).
Decroix J; Partsch H; Gonzalez R; Mobacken H; Goh CL; Walsh L; Shukla S; Naisbett B
J Eur Acad Dermatol Venereol; 2000 Jan; 14(1):23-33. PubMed ID: 10877249
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster.
Wood MJ; Johnson RW; McKendrick MW; Taylor J; Mandal BK; Crooks J
N Engl J Med; 1994 Mar; 330(13):896-900. PubMed ID: 8114860
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study.
Miserocchi E; Modorati G; Galli L; Rama P
Am J Ophthalmol; 2007 Oct; 144(4):547-51. PubMed ID: 17692271
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT.
Klein A; Miller KB; Sprague K; DesJardin JA; Snydman DR
Bone Marrow Transplant; 2011 Feb; 46(2):294-9. PubMed ID: 20421867
[TBL] [Abstract][Full Text] [Related]
17. Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study.
Kawashima M; Nemoto O; Honda M; Watanabe D; Nakayama J; Imafuku S; Kato T; Katsuramaki T;
J Dermatol; 2017 Nov; 44(11):1219-1227. PubMed ID: 28681394
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of oral acyclovir treatment of acute herpes zoster.
Wood MJ; Ogan PH; McKendrick MW; Care CD; McGill JI; Webb EM
Am J Med; 1988 Aug; 85(2A):79-83. PubMed ID: 3044098
[TBL] [Abstract][Full Text] [Related]
19. Antivirals for management of herpes zoster including ophthalmicus: a systematic review of high-quality randomized controlled trials.
McDonald EM; de Kock J; Ram FS
Antivir Ther; 2012; 17(2):255-64. PubMed ID: 22300753
[TBL] [Abstract][Full Text] [Related]
20. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group.
Fife KH; Barbarash RA; Rudolph T; Degregorio B; Roth R
Sex Transm Dis; 1997 Sep; 24(8):481-6. PubMed ID: 9293612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
